Laurence Reid Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Laurence Reid.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Laurence Reid. Laurence Reid is SVP, Chief Business Officer in ALNYLAM PHARMACEUTICALS, INC. ($ALNY).
Latest Insider Trading Transactions of Laurence Reid
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 05 2015 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 15.99 | 17,000 | 271,830 | 133,609 | |
| Jan 05 2015 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Payment of Exercise | F | 97.00 | 2,802 | 271,794 | 18,103 | 20.9 K to 18.1 K (-13.40 %) |
| Jan 05 2015 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 15.99 | 17,000 | 271,830 | 20,905 | 3.9 K to 20.9 K (+435.34 %) |
| Nov 19 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 15.99 | 3,639 | 58,188 | 150,609 | |
| Nov 19 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 9.14 | 3,861 | 35,290 | 1,728 | |
| Nov 19 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 7.10 | 2,500 | 17,750 | 12,500 | |
| Nov 19 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 91.79 | 102 | 9,362 | 3,905 | 4 K to 3.9 K (-2.55 %) |
| Nov 19 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 91.08 | 4,485 | 408,496 | 4,007 | 8.5 K to 4 K (-52.81 %) |
| Nov 19 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 90.30 | 5,413 | 488,811 | 8,492 | 13.9 K to 8.5 K (-38.93 %) |
| Nov 19 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 15.99 | 3,639 | 58,188 | 13,905 | 10.3 K to 13.9 K (+35.45 %) |
| Nov 19 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 9.14 | 3,861 | 35,290 | 10,266 | 6.4 K to 10.3 K (+60.28 %) |
| Nov 19 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 7.10 | 2,500 | 17,750 | 6,405 | 3.9 K to 6.4 K (+64.02 %) |
| Aug 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 9.14 | 11,000 | 100,540 | 5,589 | |
| Aug 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 7.10 | 2,500 | 17,750 | 15,000 | |
| Aug 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 67.80 | 7,000 | 474,620 | 3,905 | 10.9 K to 3.9 K (-64.19 %) |
| Aug 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 66.83 | 6,500 | 434,409 | 10,905 | 17.4 K to 10.9 K (-37.35 %) |
| Aug 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 9.14 | 11,000 | 100,540 | 17,405 | 6.4 K to 17.4 K (+171.74 %) |
| Aug 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 7.10 | 2,500 | 17,750 | 6,405 | 3.9 K to 6.4 K (+64.02 %) |
Page: 1